Evidence map›Paper›PMID 41432891›Full record

ArticleDiscover oncology2025

Global trends and knowledge structure of graphene based cancer research between 2016 and 2025.

Manal Mohamed Elhassan Taha, Siddig Ibrahim Abdelwahab, Hazem Mathkour, Edrous Alamer, Saleh Mohammad Abdullah, Saeed Alshahrani, Nizar A Khamjan, Abdullah Farasani, Ahmed S Alamer, Jobran M Moshi and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Manal Mohamed Elhassan TahaHealth Research Centre, Jazan University, Jazan, Saudi Arabia.
Siddig Ibrahim AbdelwahabHealth Research Centre, Jazan University, Jazan, Saudi Arabia. sadiqa@jazanu.edu.sa.
Hazem MathkourDepartment of Applied Medical Laboratories, Faculty of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
Edrous AlamerDepartment of Applied Medical Laboratories, Faculty of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
Saleh Mohammad AbdullahDepartment of Applied Medical Laboratories, Faculty of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
Saeed AlshahraniDepartment of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
Nizar A KhamjanDepartment of Applied Medical Laboratories, Faculty of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
Abdullah FarasaniDepartment of Applied Medical Laboratories, Faculty of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
Ahmed S AlamerDepartment of Health Education and Promotion, Faculty of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
Jobran M MoshiDepartment of Applied Medical Laboratories, Faculty of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
Khaled A SahliSecurity Forces Hospitals Program, General Directorate of Medical Services, Ministry of Interior, Riyadh, Saudi Arabia.
Mohammed JeraibyDepartment of Applied Medical Laboratories, Faculty of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
Marwa QadriDepartment of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
Abdulwahab BinjomahCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Khloud H AlsaadiDepartment of Biological Sciences, College of Science, Jeddah University, Jeddah, Saudi Arabia.
Hussam M ShubailyDepartment of Pathology, Faculty of Medicine, Jazan University, Jazan, Saudi Arabia.
Bandar Mushin AlamriForensic Medicine Services, Ministry of Health, 84946, Jazan, Saudi Arabia.

Funding

Jazan University 296
6 · The paper itself

Abstract

backgroundGraphene-based nanomaterials are increasingly explored for cancer diagnosis and therapy, yet a comprehensive mapping of their scholarly landscape is lacking.

methodsOn 13 March 2025, a total of 4917 records (2016-2025) were retrieved from the Scopus database using a multistep search strategy. Bibliometric indicators were analyzed with Bibliometrix (R-package), VOSviewer, and CiteSpace to evaluate research growth, collaboration, intellectual structures, and thematic evolution.

resultsPublications grew at an annual rate of 2.97%, with China leading in both productivity and citations. Bradford's Law identified 21 core journals, and leading contributors included LI Y and ZHANG Y. Collaboration networks showed dense interinstitutional and international links, particularly across Asia. Keyword and thematic analyses highlighted enduring focuses such as "graphene oxide," "drug delivery," and "biosensors," while emerging trends included "plasmon resonance biosensor," "brain tumor detection," and advanced therapeutic applications. Co-citation and overlay mapping revealed conceptual shifts toward precision diagnostics and targeted therapies.

conclusionThis study provides the first integrated bibliometric roadmap of graphene-based cancer research (2016-2025), outlining its growth trajectory, knowledge structures, and evolving themes. Findings inform researchers, funding agencies, and policymakers on current strengths, translational challenges, and priority directions for advancing graphene-based innovations in oncology.

Indexed as

Bibliometric analysisBiosensorsCancer nanotechnologyDrug deliveryGraphene oxide

Identifiers

PMID41432891
PMCPMC12834887

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.